Apollo Endosurgery Investor Relations Material
Latest events
Q3 2022
Apollo Endosurgery
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Apollo Endosurgery Inc
Access all reports
Apollo Endosurgery, Inc. designs, develops, and markets minimally invasive medical devices for gastrointestinal and bariatric procedures. Its product portfolio includes endoscopic suturing systems and devices used in weight loss therapy and the treatment of gastrointestinal complications. Apollo Endosurgery, Inc. is headquartered in Austin, Texas, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
APEN
Country
🇺🇸 United States